JRCT ID: jRCT2080220189
Registered date:19/12/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Patients with Crohn's disease in active phase |
Date of first enrollment | 19/12/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Z-206 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Remission induction rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | Patients with Crohn's disease in active phase who are defined to show CDAI of 150 or higher but less than 250, and whose lesion is mainly observed at the end of ileum or lower part. |
Exclude criteria |
Related Information
Primary Sponsor | Zeria Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050192 |
Contact
Public contact | |
Name | |
Address | kaihatu@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |